Nanoscaled Hydrated Antimony (V) Oxide as a New Approach to First-Line Antileishmanial Drugs

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s121096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Syntheses of Organic Antimony Compounds as Anti-Kala-Azar Drugs. V

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1949English

Flow Analysis-Hydride Generation-Gas Phase Derivative Molecular Absorption Spectrophotometric Determination of Antimony in Antileishmanial Drugs

Quimica Nova
Chemistry
2009English

First-Line Drugs for Hypertension

Cochrane Database of Systematic Reviews
2018English

A Novel Organotellurium Compound (RT-01) as a New Antileishmanial Agent

Korean Journal of Parasitology
ParasitologyInfectious Diseases
2009English

Endovascular Treatment as First Line Approach for Infrarenal Aortic Occlusive Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association
Medicine
2005English

Sanger Sequencing as a First-Line Approach for Molecular Diagnosis of Andersen-Tawil Syndrome

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Syntheses of Organic Antimony Compounds as Anti-Kala-Azar. Drugs. IV

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1949English

Syntheses of Organic Antimony Compounds as Anti-Kala-Azar Drugs. VIII

Yakugaku Zasshi
PharmacologyPharmaceutical Science
1949English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy